Development and production of medicinal
products to treat socially important
diseases as a fully integrated site
GEROPHARM is a national manufacturer of biotechnological products providing for medicinal safety of Russia
Investment into technological development and creation of
modern pharmaceutical infrastructure
modern pharmaceutical infrastructure
Leadership in diabetology
Development of production of active
pharmaceutical substances
pharmaceutical substances
Our mission
By developing the technology of the industry, developing and producing effective medicines, we create a healthy future.
Values of the company
Амбициозность
это идеи, созданные нашим мозгом, позволяющие превзойти себя
Страсть
зарождает огонь в нашем сердце
Ответственность
это наши руки, которые доводят дело до конца
History of the company
GEROPHARM was founded in 2001. Today GEROPHARM is a large and efficient business structure, one of the key players at the Russian pharmaceutical market and an expert of the professional community.
2001
Start of the release of original medicinal products – Cortexin®
and Retinalamin ®
and Retinalamin ®
2006
The technology
of insulin production was developed
of insulin production was developed
2011
Opening of its own
R&D Centre
R&D Centre
2013
Opening of the GEROPHARM plant
in the village of Obolensk (Moscow Region)
Start of release of generics.
Launch of
Levetinol® and Memantinol®
in the village of Obolensk (Moscow Region)
Start of release of generics.
Launch of
Levetinol® and Memantinol®
2014
Start of implementation of the project
in plant construction
in Pushkin, St. Petersburg
Opening of biotechnological
unit laboratories in
R&D Centre
in plant construction
in Pushkin, St. Petersburg
Opening of biotechnological
unit laboratories in
R&D Centre
2015
The plant in Obolensk
is able to provide for
30 % of the Russian needs
in insulin
is able to provide for
30 % of the Russian needs
in insulin
2016
More than
1.2 million packages of insulin were released
that was 82 % more
than in 2015
Launch of Pineamin®
and Recognan®
1.2 million packages of insulin were released
that was 82 % more
than in 2015
Launch of Pineamin®
and Recognan®
2017
Launch of the 1st line of the plant
in Pushkin to manufacture
pharmaceutical substances
for original medicinal products
in Pushkin to manufacture
pharmaceutical substances
for original medicinal products
2018
Launch of the 2nd line of
the plant in Pushkin
to manufacture of
insulin substances
the plant in Pushkin
to manufacture of
insulin substances
2019
Development and release
of insulin bio analogues
as the Russian market
of insulin bio analogues
as the Russian market
2020
TOP-3 among the insulin manufacturers in Russia
Rinsulin Mix 30/70, RinFast insulins, as well as Evodin and Prostatex products are registered
Winner of the Quality Award of the Government of the Russian Federation
Rinsulin Mix 30/70, RinFast insulins, as well as Evodin and Prostatex products are registered
Winner of the Quality Award of the Government of the Russian Federation
2021
GLP Compliance Status is confirmed
Basis for insulin production technology transfer to Venezuela
Marketing Authorisations for GEROPHARM insulins in Azerbaijan
Basis for insulin production technology transfer to Venezuela
Marketing Authorisations for GEROPHARM insulins in Azerbaijan
2022
Cuban GMP Certificate is received
Social Responsibility
Work in such a socially important industry as production of pharmaceutical products gives an understanding of the most urgent problems in healthcare. We are contributing to solving thereof together with public organizations, doctors and patients’ community and reporters.
2018 - CityAD - All rights reserved
Made in 